Biotronic NeuroNetwork is pleased to announce the publication of research conducted by two of its clinical leaders and the Department of Neurosurgery at Stanford University.
Arvydas Tamkus, MD, PhD, Biotronic’s Vice President, Risk Management, Clinical Research and Quality Assurance and Andrew Scott, MSE, Biotronic’s Clinical Regional Director for the Northeast joined with Fahd R. Khan, MD to publish “Intraoperative Neurophysiological Monitoring During Spinal Cord Stimulator (SCS) Placement Surgery: Retrospective Study of 111 Patients” the journal Neuromodulation.
“These initial findings indicate that EMG activation and SSEP collision are effective methods for determining the relative position of spinal cord stimulating devices on the spinal cord. Standard neuroprotective monitoring continues to identify and help resolve positional and spinal cord changes during spinal procedures.”
Biotronic continues to invest resources and clinical leadership into research for the betterment of care for all patients.
Biotronic is a patient-centric healthcare organization that provides intraoperative neurophysiological monitoring services to surgeons and healthcare facilities across the country. At Biotronic, we place patients first through our commitment to quality, service, and community.